Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2009, p. 3099-3112, Vol. 29, No. 11
0270-7306/09/$08.00+0 doi:10.1128/MCB.01845-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
,
,¶
Brian J. Hawkins,1
Subbiah Ramasamy,1
Thilagavathi Venkatachalam,1,
Partha Mukhopadhyay,3
Patrick J. Doonan,1
Krishna M. Irrinki,1
Mohanraj Rajesh,3
Pál Pacher,3 and
Craig B. Thompson2*
Department of Biochemistry, Temple University, 627 Kresge Building, 3440 N. Broad Street, Philadelphia, Pennsylvania 19140,1 Abramson Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104,2 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies, National Institutes of Health/NIAAA, Bethesda, Maryland 208923
Received 3 December 2008/ Returned for modification 6 January 2009/ Accepted 19 March 2009
Ethanol intoxication stimulates the production of proinflammatory cytokines, increases the formation of reactive oxygen species, and induces mitochondrial impairment. However, information is limited as to the exact sequence and components involved in ethanol-induced hepatotoxicity. Acute ethanol exposure enhances mitochondrial superoxide (O2.–) production and impairs mitochondrial Ca2+ handling. In turn, O2.– facilitates cytochrome c release and mitochondrial membrane potential loss that is not dependent upon H2O2 and divalent cations and requires Bak in a Bax-independent fashion. Furthermore, triggering of Bak's proapoptotic activity requires the cytosolic presence of Bid, a BH3-only protein that is processed by the initiator caspase-2. Together, these studies identify an O2.–-driven, caspase-initiated apoptotic pathway that selectively involves the Bcl-2 family proteins Bid and Bak. This pathway manifests itself during chronic ethanol consumption in aged animals and identifies caspase-2, Bid, and Bak as essential mediators of O2.–-induced apoptosis that may prove effective targets for the development of therapeutics to treat alcoholic liver disease.
Published ahead of print on 30 March 2009.
Supplemental material for this article may be found at http://mcb.asm.org/.
¶ These authors contributed equally to this work.
Present address: Department of Molecular Genetics & Microbiology, SUNY—Stony Brook, Stony Brook, NY 11794.
Present address: Department of Medicine, Cooper University Hospital, Camden, NJ 08103.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»